Frankfurt - Delayed Quote EUR
TG Therapeutics, Inc. (NKB2.F)
35.26
+0.90
+(2.63%)
At close: April 25 at 8:06:17 AM GMT+2
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| CHARNEY LAURENCE NEIL Director | Stock Gift | Mar 10, 2025 | 201,479 |
| ECHELARD YANN Director | Sale | Nov 5, 2024 | 224,098 |
| HOBERMAN KENNETH Director | Stock Award(Grant) | Jun 19, 2024 | 264,935 |
| HUME DANIEL Director | Stock Gift | Mar 17, 2025 | 178,030 |
| LONIAL SAGAR Director | Sale | Nov 11, 2024 | 100,195 |
| POWER SEAN A Chief Financial Officer | Stock Award(Grant) | Jan 29, 2025 | 708,111 |
| WEISS MICHAEL S Chief Executive Officer | Stock Award(Grant) | Jan 29, 2025 | 13,824,900 |
Related Tickers
10VA.F Immunic, Inc.
0.9870
+3.89%
FTD.SG Financière de Tubize SA
116.20
+1.40%
DR6.F ACADIA Pharmaceuticals Inc.
13.03
+2.04%
MDG1.F Medigene AG
0.1485
-1.00%
ICY.F Incyte Corporation
51.80
+1.81%
PRTC.L PureTech Health plc
125.60
-1.72%
TUB.BR Financière de Tubize SA
118.40
+1.72%
22UA.DE BioNTech SE
102.10
-0.10%
TNFA TNF Pharmaceuticals, Inc.
0.2200
+14.58%
RARE Ultragenyx Pharmaceutical Inc.
38.09
+1.20%